Covid- 19 and Myocardium

Authors

Iman Razeghian-JahromiIman Razeghian-Jahromi ORCID1, Zahra ElyaspourZahra Elyaspour ORCID1, Zahra DaneshvarZahra  Daneshvar ORCID1, Mohammad Javad ZibaeenezhadMohammad Javad  Zibaeenezhad ORCID1,*
1Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
*Corresponding Author: Cardiovascular Research Center, Mohammad Rasoul-allah Research Tower, Mollasadra Street, Shiraz, Iran, Tel: +98-71-36122238, Email: [email protected].[email protected]

International Cardiovascular Research Journal:Vol. 14, issue 3; e107069
Published online:Sep 01, 2020
Article type:Review Article
Received:Jun 30, 2020
Accepted:Aug 01, 2020
How to Cite:Razeghian-Jahromi I, Elyaspour Z, Daneshvar Z, Zibaeenezhad MJ. Covid- 19 and Myocardium. Int Cardiovasc Res J. 2020;14(3):e107069. doi:

Abstract

Context:
The COVID-19 pandemic has involved several millions of people around the world and has dragged thousands of individuals to death. Unfortunately, it seems to be unstoppable for the near future. This review aimed to have a comprehensive appraisal on the latest studies conducted on different aspects of myocardial injury related to COVID-19.
Evidence Acquisition:
The researchers searched for accredited international investigations, whether original, review, letters, or commentaries or any other published data, in Pubmed/Medline, Google Scholar, Web of Science, Wiley Online Library, and Research Gate databases.
Results:
Although the dominant manifestation of the disease was related to the respiratory system, a growing body of evidence has suggested that the cardiovascular system was also a target for SARS-CoV-2. In this regard, myocardium suffered injury by possible direct and indirect mechanisms. Two patterns of myocardial injury were seen particularly in critical cases of COVID-19; presentation with acute myocardial injury and development of myocardial injury with escalation of the viral illness. In the case of myocardial damage, a cascade of life-threatening adverse events will deteriorate the functions of the cardiovascular system as well as other vital organs. Cardiac biomarkers are helpful for early diagnosis of myocardial injury. Hypertension, previous cardiovascular diseases, and diabetes have been considered to be the foremost clinical risk factors in the setting of COVID-19. The jeopardy of arrhythmia, thrombotic complications, acute myocardial infarction, and myocarditis are also anticipated in patients with COVID-19. Thrombolytics have been found to contribute substantially to life-saving treatment regimen.
Conclusions:
Cardiovascular damage in terms of myocardial injury has been assigned a considerable share in patients with COVID-19, which is of paramount importance due to the elevation of the fatality rate. While there is no exclusive medication for this viral uninvited guest, much attention should be paid to maintenance of cardiovascular health, which plays a critical role in the battlefield with COVID-19.
 

Highlights

Fulltext

The full-text is available in pdf.

References

  • 1.
    The references are available in pdf.

Copyright

© 2020, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

15
Mar
2021

A Case of Multiple Large Left Ventricular Clots in a Patient with COVID-19

Azin Alizadehasl,
Soudeh Roudbari,
Pegah Salehi,
Alireza Sistani,
Atousa Mostafavi,
Hossein Kamranzadeh Fumani
,et al.

Alizadehasl A, Roudbari S, Salehi P, Sistani A, Mostafavi A, et al. A Case of Multiple Large Left Ventricular Clots in a Patient with COVID-19. Int Cardiovasc Res J. 2021;15(1):e107642. doi:

27
Apr
2020
COVID-19 and Heart Disease

COVID-19 and Heart Disease

Masoud Eslami,
Reza Mollazadeh

Eslami M, Mollazadeh R. COVID-19 and Heart Disease. Arch Neurosci. 2020;7(2):e103976. doi: https://doi.org/10.5812/ans.103976

10
Aug
2020
Complicated AMI in a COVID-19 Patient; Chordal Rupture and Flail of Mitral Valve

Complicated AMI in a COVID-19 Patient; Chordal Rupture and Flail of Mitral Valve

Azin Alizadehasl,
Pegah Salehi,
Soudeh Roudbari,
Mehrdad Jafari Fesharaki,
Maryam Moradian,
Ata Firouzi
,et al.

Alizadehasl A, Salehi P, Roudbari S, Fesharaki MJ, Moradian M, et al. Complicated AMI in a COVID-19 Patient; Chordal Rupture and Flail of Mitral Valve. Multidiscip Cardio Annal. 2020;11(2):e106953. doi: https://doi.org/10.5812/mca.106953

15
Apr
2020
Underlying Chronic Disease and COVID-19 Infection: A State-of-the-Art Review

Underlying Chronic Disease and COVID-19 Infection: A State-of-the-Art Review

Habib Haybar,
Khalil Kazemnia,
Fakher Rahim

Haybar H, Kazemnia K, Rahim F. Underlying Chronic Disease and COVID-19 Infection: A State-of-the-Art Review. Jundishapur J Chronic Dis Care. 2020;9(2):e103452. doi: https://doi.org/10.5812/jjcdc.103452

30
Mar
2021

The Prevalence of Cardiovascular Risk Factors in Fatal Cases of COVID-19 in Fars Province, Iran

Mohammad Javad Zibaeenezhad,
Mehrab Sayadi,
Hamed Bazrafshan Drissi,
Zahra Daneshvar,
Nader Parsa,
Navid Farshadi
,et al.

Zibaeenezhad MJ, Sayadi M, Bazrafshan Drissi H, Daneshvar Z, Parsa N, et al. The Prevalence of Cardiovascular Risk Factors in Fatal Cases of COVID-19 in Fars Province, Iran. Int Cardiovasc Res J. 2021;15(1):e112945. doi:

More by these authors

Iman Razeghian-JahromiPubMedScholar
Zahra ElyaspourPubMedScholar
Zahra DaneshvarPubMedScholar
Mohammad Javad ZibaeenezhadPubMedScholar
Share
Cited by
Metrics
Indexed in